Preoperative immunochemotherapy for locally advanced non-small cell lung cancer: an analysis of the clinical outcomes, optimal number of cycles, and peripheral immune markers

BACKGROUND: This retrospective study aimed to evaluate the real-world efficacy of neoadjuvant immunochemotherapy in locally advanced stage III non-small cell lung cancer (NSCLC), with a particular focus on analyzing the optimal treatment cycle and peripheral immune markers. METHODS: Eligible patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Hongsheng, Liang, Hengrui, Chen, Jiawei, Wang, Wei, Li, Jianfu, Xiong, Shan, Cheng, Bo, Li, Caichen, Chen, Zhuxing, Wang, Haixuan, Zheng, Jianqi, Guo, Zhuoxuan, He, Jianxing, Liang, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830256/
https://www.ncbi.nlm.nih.gov/pubmed/36636407
http://dx.doi.org/10.21037/tlcr-22-439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830256/
https://www.ncbi.nlm.nih.gov/pubmed/36636407
http://dx.doi.org/10.21037/tlcr-22-439

Ejemplares similares